Prosonix aims to leverage its particle engineering technology and respiratory drug development expertise to develop inhaled products that offer performance and cost benefits, as well as greater choice, to patients, physicians and payors.
Terms & Conditions
© Prosonix Ltd, 2016
The Medawar Centre   Robert Robinson Avenue   Oxford Science Park   Oxford   OX4 4GA   United Kingdom   |   Tel: +44 (0)1865 784250   |   Email: Here